CG
RDY icon

Cutler Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Cutler Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5
Closed – – 5068
2017
Q4 		$0 Buy
+5
New +$36 ﹤0.01% 5736
2017
Q3 		– Sell
-1,230
Closed -$10K – 6551
2017
Q2 		$10K Hold
1,230
– – ﹤0.01% 4172
2017
Q1 		$9K Sell
1,230
-6,020
-83% -$52K ﹤0.01% 4170
2016
Q4 		$65K Sell
7,250
-1,500
-17% -$14K ﹤0.01% 2298
2016
Q3 		$81K Buy
8,750
+1,500
+21% +$14.3K ﹤0.01% 1989
2016
Q2 		$74K Sell
7,250
-4,500
-38% -$41.2K ﹤0.01% 1976
2016
Q1 		$106K Sell
11,750
-22,600
-66% -$202K 0.01% 1553
2015
Q4 		$318K Buy
+34,350
New +$376K 0.02% 851

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cutler Group's RDY Position: Q1 2018 in Review

Cutler Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2018, closing a stake of 5 shares.

Cutler Group first reported a position in RDY in Q4 2015 and held it in 8 quarters. The position peaked at $318K in Q4 2015. 121 funds tracked by Wall St. Rank hold RDY as of Q1 2018.

  • Cutler Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2018 after selling out during the quarter.
  • Cutler Group sold 5 Dr. Reddy's Laboratories shares in Q1 2018.
  • Cutler Group first reported a position in Dr. Reddy's Laboratories in Q4 2015 and held it in 8 quarters.
  • Cutler Group's Dr. Reddy's Laboratories position peaked at $318K in Q4 2015.
  • 121 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2018.

Based on Cutler Group's 13F filing for Q1 2018, filed 11 May 2018.